Company / Shares Outstanding
CUMBERLAND PHARMACEUTICALS INC Shares Outstanding History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Shares Outstanding
14.0M
FY2025
5-year range
14.0M / 15.0M
FY2021-FY2025
Trend
-1.2%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Shares Outstanding has declined for 7 consecutive years, from 16074176.00 in FY2018 to 13952624.00 in FY2025.
Based on SEC 10-K filings.
13952624.00 in FY2025 with a 5-year CAGR of -1.8%.
Improved from 14366316.00 to 13952624.00 over the past 2 years.
Shares Outstanding over time
Growth rates
- 3-Year CAGR
- -1.8%
- 5-Year CAGR
- -1.8%
- 10-Year CAGR
- -
Key checks
Key Insights
- CUMBERLAND PHARMACEUTICALS INC's shares outstanding has declined for 7 consecutive years.
- In FY2025, shares outstanding decreased 1.2% year-over-year.
- Peak shares outstanding was recorded in FY2016.
Company context
Key Data Points
- Altman Z-Score 0.11 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Shares OutstandingValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | 14.0M | -1.2% |
| FY2024 | 14.1M | -1.7% |
| FY2023 | 14.4M | -2.6% |
| FY2022 | 14.7M | -1.6% |
| FY2021 | 15.0M | -1.8% |
| FY2020 | 15.3M | -1.4% |
| FY2019 | 15.5M | -3.7% |
| FY2018 | 16.1M | +0.0% |
| FY2017 | 16.1M | -1.9% |
| FY2016 | 16.4M | -4.3% |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026